- £198.21bn
- £217.54bn
- $54.07bn
- 85
- 16
- 86
- 71
REG - AstraZeneca PLC - Durvalumab granted BTD by FDA for cancer patients <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - NEW EXTERNAL BOARD APPOINTMENT <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - AstraZeneca Full-Year and Q4 2015 Results <Origin Href="QuoteRef">AZN.L</Origin> - Part 3
AnnouncementREG - AstraZeneca PLC - AstraZeneca Full-Year and Q4 2015 Results <Origin Href="QuoteRef">AZN.L</Origin> - Part 4
AnnouncementREG - AstraZeneca PLC - AstraZeneca Full-Year and Q4 2015 Results <Origin Href="QuoteRef">AZN.L</Origin> - Part 1
AnnouncementREG - AstraZeneca PLC - AstraZeneca Full-Year and Q4 2015 Results <Origin Href="QuoteRef">AZN.L</Origin> - Part 2
AnnouncementREG - AstraZeneca PLC - Notice of Results <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - TAGRISSO approved in EU for cancer patients <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - AZ Completes transaction with Acerta Pharma <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Total Voting Rights <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Lynparza Granted BTD in US for Prostate Cancer <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Total Voting Rights <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Result of External Audit Tender <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - LESINURAD APPROVED BY US FDA FOR GOUT <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - TAGRISSOT (OSIMERTINIB) POSITIVE CHMP OPINION <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - BRILIQUE (TICAGRELOR) POSITIVE EU CHMP OPINION <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - CHMP ISSUES POSITIVE OPINION ON LESINURAD FOR GOUT <Origin Href="QuoteRef">AZN.L</Origin>
Announcement